These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31904196)

  • 1. Reprogramming of human fibroblasts into osteoblasts by insulin-like growth factor-binding protein 7.
    Lu Z; Chiu J; Lee LR; Schindeler A; Jackson M; Ramaswamy Y; Dunstan CR; Hogg PJ; Zreiqat H
    Stem Cells Transl Med; 2020 Mar; 9(3):403-415. PubMed ID: 31904196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Δ133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells.
    Horikawa I; Park KY; Isogaya K; Hiyoshi Y; Li H; Anami K; Robles AI; Mondal AM; Fujita K; Serrano M; Harris CC
    Cell Death Differ; 2017 Jun; 24(6):1017-1028. PubMed ID: 28362428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Osteoblasts by Direct Reprogramming of Mouse Fibroblasts.
    Zhu H; Wu JY
    Methods Mol Biol; 2020; 2155():201-212. PubMed ID: 32474879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGFBP7 regulates the osteogenic differentiation of bone marrow-derived mesenchymal stem cells via Wnt/β-catenin signaling pathway.
    Zhang W; Chen E; Chen M; Ye C; Qi Y; Ding Q; Li H; Xue D; Gao X; Pan Z
    FASEB J; 2018 Apr; 32(4):2280-2291. PubMed ID: 29242275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines.
    Wajapeyee N; Kapoor V; Mahalingam M; Green MR
    Mol Cancer Ther; 2009 Nov; 8(11):3009-14. PubMed ID: 19861408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer.
    Okamura J; Huang Y; Moon D; Brait M; Chang X; Kim MS
    Cancer Biol Ther; 2012 Feb; 13(3):148-55. PubMed ID: 22277373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
    Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
    Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Reprogramming of Fibroblasts to Osteoblasts: Techniques and Methodologies.
    Fallah A; Beke A; Oborn C; Soltys CL; Kannu P
    Stem Cells Transl Med; 2024 Apr; 13(4):362-370. PubMed ID: 38159082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions.
    Kveiborg M; Flyvbjerg A; Rattan SI; Kassem M
    Exp Gerontol; 2000 Oct; 35(8):1061-74. PubMed ID: 11121690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7.
    Wajapeyee N; Serra RW; Zhu X; Mahalingam M; Green MR
    Cell; 2008 Feb; 132(3):363-74. PubMed ID: 18267069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
    Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
    J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP7 acts as a negative regulator of RANKL-induced osteoclastogenesis and oestrogen deficiency-induced bone loss.
    Ye C; Hou W; Chen M; Lu J; Chen E; Tang L; Hang K; Ding Q; Li Y; Zhang W; He R
    Cell Prolif; 2020 Feb; 53(2):e12752. PubMed ID: 31889368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Reprogramming of Mouse Fibroblasts into Functional Osteoblasts.
    Zhu H; Swami S; Yang P; Shapiro F; Wu JY
    J Bone Miner Res; 2020 Apr; 35(4):698-713. PubMed ID: 31793059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-beta signaling.
    Pen A; Moreno MJ; Durocher Y; Deb-Rinker P; Stanimirovic DB
    Oncogene; 2008 Nov; 27(54):6834-44. PubMed ID: 18711401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct conversion of human fibroblasts into functional osteoblasts by defined factors.
    Yamamoto K; Kishida T; Sato Y; Nishioka K; Ejima A; Fujiwara H; Kubo T; Yamamoto T; Kanamura N; Mazda O
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6152-7. PubMed ID: 25918395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct conversion of mouse embryonic fibroblast to osteoblast cells using hLMP-3 with Yamanaka factors.
    Ahmed MF; El-Sayed AK; Chen H; Zhao R; Jin K; Zuo Q; Zhang Y; Li B
    Int J Biochem Cell Biol; 2019 Jan; 106():84-95. PubMed ID: 30453092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.
    Benatar T; Yang W; Amemiya Y; Evdokimova V; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2012 Jun; 133(2):563-73. PubMed ID: 21997538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct phenotypic conversion of human fibroblasts into functional osteoblasts triggered by a blockade of the transforming growth factor-β signal.
    Yamamoto K; Kishida T; Nakai K; Sato Y; Kotani SI; Nishizawa Y; Yamamoto T; Kanamura N; Mazda O
    Sci Rep; 2018 May; 8(1):8463. PubMed ID: 29855543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
    Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
    Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.